The cytotoxicity of the brown alga Sargassum siliquastrum on human cancer cells (AGS, HT-29, HT-1080, and MCF-7) was investigated. Bioassay-guided fractionation of the crude extracts showed that the 85% aq. methanol (MeOH) fraction was the most toxic. Seven known meroterpenoids (1-7) were isolated from this cytotoxic fraction. Each compound was evaluated for its cytotoxic effect on human cancer cells. Compounds 1, 2, and 4 showed strong cytotoxicity against AGS, HT-29, and HT-1080 cell lines, with IC 50 values ranging from 0.5 to 5.7 g/mL.
Cancer is one of the major fatal diseases to humans in the twentyfirst century, responsible for millions of deaths annually [1] . Despite many therapeutic advances, mortality is still unacceptably high. Chemotherapy is one of the most widely used tools for the treatment of many cancers, but its long-term use can lead to drug resistance via several different mechanisms [2] . Due to this resistance to conventional cancer drugs, it is important to find new anticancer agents that can circumvent the existing resistance mechanisms. In recent years, there has been growing interest in searching for anticancer agents from natural sources, especially marine organisms [3a-e] . As part of our systematic investigation of the cytotoxic activity of algae found off the coastal area of South Korea, this article evaluates the in vitro cytotoxic effects of S. siliquastrum extract and its constituents against human cancer cell lines, such as AGS (human gastric cancer), HT-29 (human colon cancer), HT-1080 (human fibrosarcoma), and MCF-7 (human breast adenocarcinoma).
The in vitro cytotoxic activity of the extracts and fractions was assessed using four different human tumor cell lines: stomach (AGS), colon (HT-29), fibrosarcoma (HT-1080), and breast (MCF-7). The extracts and fractions were used at concentrations ranging from 5 to 100 g/mL. The cytotoxic activity (g/mL) of the tested extracts and fractions is given by the IC 50 parameter for each cell line assayed. The combined crude extracts were further separated into four fractions, n-hexane, 85% aq.MeOH, n-BuOH, and H 2 O, which were assayed against the same cells. The cytotoxic activity of two crude extracts and their solvent fractions is showed in Table  1 . Of the four solvent fractions tested, the 85% aq.MeOH fraction showed the highest cytotoxicity against AGS, HT-29, HT-1080, and MCF-7 cells.
The 85% aq.MeOH fraction was then subjected to sequential reversed-phase column chromatography followed by reversed-phase HPLC. Compounds 1-7 were obtained from this fraction and identified as the meroterpenoids, sargachromanol E (1), sargachromanol D (2), sargachromanol K (3), sargachromanol P (4), (9S * ,10S * )-13-(3,4-dihydro-6-hydroxy-2,8-dimethy-2H-1-benzopyran-2-yl)-2,6,10-trimethyl-trideca-(2E,6E)-diene-4,5,10-triol (5) pyran-2-yl)-2,6,10-trimethyl-trideca-(2E,6E)-diene-4,5,10-triol (6), and 9-(3,4-dihydro-6-hydroxy-2,8-dimethy-2H-1-benzopyran-2-yl)-2,6-dimethyl-(6E)-nonenoic acid (7), by comparison with authentic samples and the spectroscopic data reported in the literature [3f,g] .
Some chromene metabolites and related structural classes isolated from brown algae are known to exhibit good cytotoxic activity [4a] . All seven isolated meroterpenoids (1) (2) (3) (4) (5) (6) (7) were tested for their cytotoxicities against human cancer cell lines in vitro using the MTT assay. The results are presented in Table 1 . AGS, HT-29, and HT-1080 cells were more sensitive to the compounds than MCF-7 cells. All compounds revealed potent cytotoxicity against all cell lines assayed. In particular, sargachromanols A (1), B (2), and K (4) displayed strong cytotoxicity to AGS, HT-29, HT-1080, 
